Updated:
Korea Bio Medical Science Institute
Korea Bio Medical Science Institute (KBMSI) was founded in 2009. The firm focuses on developing health food and medical supplies through the combination of...
Korea Bio Medical Science Institute
Korea Bio Medical Science Institute (KBMSI) was founded in 2009. The firm focuses on developing health food and medical supplies through the combination of traditional oriental medicine and modern science. KBMSI has made one investment, in Emmaus Life Sciences, as part of an unattributed Series II round on January 26, 2016.
General information
Firm type
other
Location
Region
Asia
Country
South Korea
City
Seoul
Corporate office
Seoul, South Korea
Sector focus
Frequently asked questions
What is the Korea Bio Medical Science Institute's core investment focus?
The institute targets biomedical science and digital health, with emphasis on early-stage ventures in AI diagnostics, biomarker discovery, and translational medicine. Its model combines research funding with equity investment, often supporting projects from lab to clinical stage. Publicly available details on specific portfolio companies are limited.
Does the institute invest beyond South Korea?
Geographic focus is primarily South Korea. There is no public evidence of direct investments outside Asia, though collaborations with peers in Singapore or Japan are plausible given regional biomedical research networks. Expansion abroad, if it occurs, has not been formally disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: